https://www.selleckchem.com/products/mbx-8025.html
05). Hypertension, HF, LVEF 40%, CAD, prior MI and tobacco use were determined to be predictors of ACEI/ARB treatment. Multivariable analysis showed that ACEI/ARB therapy was associated with a significantly lower risk of one-year all-cause mortality [hazard ratio (HR) (95% CI) 0.682 (0.527-0.882), = 0.003], cardiovascular mortality [HR (95% CI) 0.713 (0.514-0.988), = 0.042] and MAEs [HR (95% CI) 0.698 (0.568-0.859), = 0.001]. The association between ACEI/ARB therapy and reduced mortality was consistent in the subgroup analysis. In
Like
Comment
Share
